{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:33:14Z","timestamp":1780075994788,"version":"3.54.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the world, and its pathogenesis is not fully understood. Disulfidptosis is the most recently reported form of cell death and may be associated with NAFLD progression. Our study aimed to explore the molecular clusters associated with disulfidptosis in NAFLD and to construct a predictive model.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> First, we analyzed the expression profile of the disulfidptosis regulators and immune characteristics in NAFLD. Using 104 NAFLD samples, we investigated molecular clusters based on differentially expressed disulfidptosis-related genes, along with the related immune cell infiltration. Cluster-specific differentially expressed genes were then identified by using the WGCNA method. We also evaluated the performance of four machine learning models before choosing the optimal machine model for diagnosis. Nomogram, calibration curves, decision curve analysis, and external datasets were used to confirm the prediction effectiveness. Finally, the expression levels of the biomarkers were assessed in a mouse model of a high-fat diet.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Two differentially expressed DRGs were identified between healthy and NAFLD patients. We revealed the expression profile of DRGs in NAFLD and the correlation with 22 immune cells. In NAFLD, two clusters of molecules connected to disulfidptosis were defined. Significant immunological heterogeneity was shown by immune infiltration analysis among the various clusters. A significant amount of immunological infiltration was seen in Cluster 1. Functional analysis revealed that Cluster 1 differentially expressed genes were strongly linked to energy metabolism and immune control. The highest discriminatory performance was demonstrated by the SVM model, which had a higher area under the curve, relatively small residual and root mean square errors. Nomograms, calibration curves, and decision curve analyses were used to show how accurate the prediction of NAFLD was. Further analysis revealed that the expression of three model-related genes was significantly associated with the level of multiple immune cells. In animal experiments, the expression trends of DDO, FRK and TMEM19 were consistent with the results of bioinformatics analysis.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study systematically elucidated the complex relationship between disulfidptosis and NAFLD and developed a promising predictive model to assess the risk of disease in patients with disulfidptosis subtypes and NAFLD.<\/jats:p>","DOI":"10.3389\/fgene.2023.1251999","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T10:22:17Z","timestamp":1694168537000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaoxiao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1113634","DOI":"10.3389\/fimmu.2023.1113634","article-title":"Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis","volume":"14","author":"Bao","year":"2023","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/circresaha.119.316337","article-title":"Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases","volume":"126","author":"Cai","year":"2020","journal-title":"Circ. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/bioinformatics\/bts715","article-title":"In silico identification of oncogenic potential of fyn-related kinase in hepatocellular carcinoma","volume":"29","author":"Chen","year":"2013","journal-title":"Bioinformatics"},{"key":"B7","first-page":"785","article-title":"Xgboost: A scalable tree boosting system","author":"Chen","year":"2016"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2009.02.341","article-title":"Homocysteine and lipoprotein (a) correlation in ischemic stroke patients","volume":"281","author":"Dhamija","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.3390\/ijms22115528","article-title":"P2Y2R deficiency ameliorates hepatic steatosis by reducing lipogenesis and enhancing fatty acid \u03b2-oxidation through AMPK and PGC-1\u03b1 induction in high-fat diet-fed mice","volume":"22","author":"Dusabimana","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","author":"European Association for the Study of the Liver","year":"2016","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0124544","DOI":"10.1371\/journal.pone.0124544","article-title":"Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease","volume":"10","author":"Frades","year":"2015","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1042442","DOI":"10.3389\/fnins.2022.1042442","article-title":"Non-alcoholic fatty liver disease (NAFLD) and mental illness: mechanisms linking mood, metabolism and medicines","volume":"16","author":"Gangopadhyay","year":"2022","journal-title":"Front. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbcan.2015.05.001","article-title":"Tracing the footprints of the breast cancer oncogene BRK - past till present","volume":"1856","author":"Goel","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10555-016-9623-3","article-title":"Understanding the cellular roles of fyn-related kinase (FRK): implications in cancer biology","volume":"35","author":"Goel","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0925-2312(03)00375-8","article-title":"Model selection for support vector machine classification","volume":"55","author":"Gold","year":"2003","journal-title":"Neurocomputing"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"Gsva: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.1038\/s41598-023-39563-y","article-title":"A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma","volume":"13","author":"Hu","year":"2023","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1189\/jlb.1206763","article-title":"Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation","volume":"82","author":"Hu","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7561645","DOI":"10.1155\/2021\/7561645","article-title":"Identification of key genes and immune infiltrate in nonalcoholic steatohepatitis: A bioinformatic analysis","volume":"2021","author":"Jiang","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-213x-9-70","article-title":"Isolation and characterization of a novel plasma membrane protein, osteoblast induction factor (obif), associated with osteoblast differentiation","volume":"9","author":"Kanamoto","year":"2009","journal-title":"BMC Dev. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","article-title":"Mfuzz: A software package for soft clustering of microarray data","volume":"2","author":"Kumar","year":"2007","journal-title":"Bioinformation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"Wgcna: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinforma."},{"key":"B25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8463640","DOI":"10.1155\/2022\/8463640","article-title":"Bidirectional association between hypertension and NAFLD: A systematic review and meta-analysis of observational studies","volume":"2022","author":"Li","year":"2022","journal-title":"Int. J. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nchembio.332","article-title":"A chemical and phosphoproteomic characterization of dasatinib action in lung cancer","volume":"6","author":"Li","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: A systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11894-020-00786-y","article-title":"Emerging new diagnostic modalities and therapies of nonalcoholic fatty liver disease","volume":"22","author":"Lin","year":"2020","journal-title":"Curr. Gastroenterol. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41398-022-02088-5","article-title":"D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans","volume":"12","author":"Lombardo","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3892\/mmr.2020.10959","article-title":"A six-gene support vector machine classifier contributes to the diagnosis of pediatric septic shock","volume":"21","author":"Long","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2156483","DOI":"10.1155\/2022\/2156483","article-title":"Association of serum homocysteine with cardiovascular and all-cause mortality in adults with Diabetes: A prospective cohort study","volume":"2022","author":"Lu","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2010.04.077","article-title":"D-aspartate activates mGlu receptors coupled to polyphosphoinositide hydrolysis in neonate rat brain slices","volume":"478","author":"Molinaro","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1096\/fj.201901703R","article-title":"Structure and kinetic properties of human d-aspartate oxidase, the enzyme-controlling d-aspartate levels in brain","volume":"34","author":"Molla","year":"2020","journal-title":"Faseb J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2307\/2344614","article-title":"Generalized linear models","volume":"135","author":"Nelder","year":"1972","journal-title":"J. R. Stat. Soc. Ser. A General."},{"key":"B37","first-page":"1073","article-title":"Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD)","volume":"8","author":"Ni","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1007\/s10620-018-5268-0","article-title":"Silybin alleviates hepatic steatosis and fibrosis in NASH mice by inhibiting oxidative stress and involvement with the nf-\u03bab pathway","volume":"63","author":"Ou","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8848","DOI":"10.1038\/s41598-020-65051-8","article-title":"Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"10","author":"Pan","year":"2020","journal-title":"Sci. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.coph.2021.07.007","article-title":"An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: progress and opportunities","volume":"60","author":"Pan","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J. Hepatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","article-title":"Adipokines in nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13659","DOI":"10.1111\/eci.13659","article-title":"Is there an 'ideal' diet for patients with NAFLD?","volume":"52","author":"Pugliese","year":"2022","journal-title":"Eur. J. Clin. Invest."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8960","DOI":"10.18632\/aging.202717","article-title":"Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2","volume":"13","author":"Qian","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"761538","DOI":"10.3389\/fmed.2021.761538","article-title":"Liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies","volume":"8","author":"Qu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.17849\/insm-47-01-31-39.1","article-title":"Random forest","volume":"47","author":"Rigatti","year":"2017","journal-title":"J. Insur Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"637","DOI":"10.14336\/ad.2018.0513","article-title":"The anti-inflammatory and anti-oxidant mechanisms of the keap1\/nrf2\/ARE signaling pathway in chronic diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"704704","DOI":"10.3389\/fcell.2021.704704","article-title":"Comprehensive analysis of NAFLD and the therapeutic target identified","volume":"9","author":"Wen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/eji.201041349","article-title":"Adiponectin is a negative regulator of antigen-activated T cells","volume":"41","author":"Wilk","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1053\/j.gastro.2015.05.039","article-title":"High prevalence of nonalcoholic fatty liver disease in adolescents undergoing bariatric surgery","volume":"149","author":"Xanthakos","year":"2015","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2009.02.012","article-title":"Rak functions as a tumor suppressor by regulating PTEN protein stability and function","volume":"15","author":"Yim","year":"2009","journal-title":"Cancer Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/cne.10320","article-title":"Cellular and subcellular distribution of D-aspartate oxidase in human and rat brain","volume":"450","author":"Zaar","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5633211","DOI":"10.1155\/2021\/5633211","article-title":"WGCNA-based identification of hub genes and key pathways involved in nonalcoholic fatty liver disease","volume":"2021","author":"Zeng","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"942153","DOI":"10.3389\/fgene.2022.942153","article-title":"Integrated bioinformatics analysis identifies robust biomarkers and its correlation with immune microenvironment in nonalcoholic fatty liver disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Genet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"106724","DOI":"10.1016\/j.compbiomed.2023.106724","article-title":"Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies","volume":"157","author":"Zhang","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1090040","DOI":"10.3389\/fimmu.2023.1090040","article-title":"Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-023-02675-4","article-title":"Disulfidptosis: A new target for metabolic cancer therapy","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1251999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T10:22:35Z","timestamp":1694168555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1251999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":59,"alternative-id":["10.3389\/fgene.2023.1251999"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1251999","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"article-number":"1251999"}}